Clinical Trial Update: A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence [NA]

View source ↗

Summary

A completed randomized, blinded multicenter study evaluating NASHA/Dx for fecal incontinence; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• NASHA/Dx

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Fecal Incontinence | NA | Status: COMPLETED | Results posted: 2020-08-18